Cargando…
ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery
Conventional immunoprecipitation/mass spectroscopy identification of HLA-restricted peptides remains the purview of specializing laboratories, due to the complexity of the methodology, and requires computational post-analysis to assign peptides to individual alleles when using pan-HLA antibodies. We...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111693/ https://www.ncbi.nlm.nih.gov/pubmed/33986749 http://dx.doi.org/10.3389/fimmu.2021.658372 |
_version_ | 1783690552219271168 |
---|---|
author | Finton, Kathryn A. K. Brusniak, Mi-Youn Jones, Lisa A. Lin, Chenwei Fioré-Gartland, Andrew J. Brock, Chance Gafken, Philip R. Strong, Roland K. |
author_facet | Finton, Kathryn A. K. Brusniak, Mi-Youn Jones, Lisa A. Lin, Chenwei Fioré-Gartland, Andrew J. Brock, Chance Gafken, Philip R. Strong, Roland K. |
author_sort | Finton, Kathryn A. K. |
collection | PubMed |
description | Conventional immunoprecipitation/mass spectroscopy identification of HLA-restricted peptides remains the purview of specializing laboratories, due to the complexity of the methodology, and requires computational post-analysis to assign peptides to individual alleles when using pan-HLA antibodies. We have addressed these limitations with ARTEMIS: a simple, robust, and flexible platform for peptide discovery across ligandomes, optionally including specific proteins-of-interest, that combines novel, secreted HLA-I discovery reagents spanning multiple alleles, optimized lentiviral transduction, and streamlined affinity-tag purification to improve upon conventional methods. This platform fills a middle ground between existing techniques: sensitive and adaptable, but easy and affordable enough to be widely employed by general laboratories. We used ARTEMIS to catalog allele-specific ligandomes from HEK293 cells for seven classical HLA alleles and compared results across replicates, against computational predictions, and against high-quality conventional datasets. We also applied ARTEMIS to identify potentially useful, novel HLA-restricted peptide targets from oncovirus oncoproteins and tumor-associated antigens. |
format | Online Article Text |
id | pubmed-8111693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81116932021-05-12 ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery Finton, Kathryn A. K. Brusniak, Mi-Youn Jones, Lisa A. Lin, Chenwei Fioré-Gartland, Andrew J. Brock, Chance Gafken, Philip R. Strong, Roland K. Front Immunol Immunology Conventional immunoprecipitation/mass spectroscopy identification of HLA-restricted peptides remains the purview of specializing laboratories, due to the complexity of the methodology, and requires computational post-analysis to assign peptides to individual alleles when using pan-HLA antibodies. We have addressed these limitations with ARTEMIS: a simple, robust, and flexible platform for peptide discovery across ligandomes, optionally including specific proteins-of-interest, that combines novel, secreted HLA-I discovery reagents spanning multiple alleles, optimized lentiviral transduction, and streamlined affinity-tag purification to improve upon conventional methods. This platform fills a middle ground between existing techniques: sensitive and adaptable, but easy and affordable enough to be widely employed by general laboratories. We used ARTEMIS to catalog allele-specific ligandomes from HEK293 cells for seven classical HLA alleles and compared results across replicates, against computational predictions, and against high-quality conventional datasets. We also applied ARTEMIS to identify potentially useful, novel HLA-restricted peptide targets from oncovirus oncoproteins and tumor-associated antigens. Frontiers Media S.A. 2021-04-23 /pmc/articles/PMC8111693/ /pubmed/33986749 http://dx.doi.org/10.3389/fimmu.2021.658372 Text en Copyright © 2021 Finton, Brusniak, Jones, Lin, Fioré-Gartland, Brock, Gafken and Strong https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Finton, Kathryn A. K. Brusniak, Mi-Youn Jones, Lisa A. Lin, Chenwei Fioré-Gartland, Andrew J. Brock, Chance Gafken, Philip R. Strong, Roland K. ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery |
title | ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery |
title_full | ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery |
title_fullStr | ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery |
title_full_unstemmed | ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery |
title_short | ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery |
title_sort | artemis: a novel mass-spec platform for hla-restricted self and disease-associated peptide discovery |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111693/ https://www.ncbi.nlm.nih.gov/pubmed/33986749 http://dx.doi.org/10.3389/fimmu.2021.658372 |
work_keys_str_mv | AT fintonkathrynak artemisanovelmassspecplatformforhlarestrictedselfanddiseaseassociatedpeptidediscovery AT brusniakmiyoun artemisanovelmassspecplatformforhlarestrictedselfanddiseaseassociatedpeptidediscovery AT joneslisaa artemisanovelmassspecplatformforhlarestrictedselfanddiseaseassociatedpeptidediscovery AT linchenwei artemisanovelmassspecplatformforhlarestrictedselfanddiseaseassociatedpeptidediscovery AT fioregartlandandrewj artemisanovelmassspecplatformforhlarestrictedselfanddiseaseassociatedpeptidediscovery AT brockchance artemisanovelmassspecplatformforhlarestrictedselfanddiseaseassociatedpeptidediscovery AT gafkenphilipr artemisanovelmassspecplatformforhlarestrictedselfanddiseaseassociatedpeptidediscovery AT strongrolandk artemisanovelmassspecplatformforhlarestrictedselfanddiseaseassociatedpeptidediscovery |